Results 181 to 190 of about 34,622 (239)
Some of the next articles are maybe not open access.

Synthesis of 5-Trimethylsilylethynyl-1,3,4-oxadiazoles

Russian Journal of Organic Chemistry, 2003
AbstractFor Abstract see ChemInform Abstract in Full Text.
M. M. Demina   +4 more
openaire   +1 more source

1,3,4-Oxadiazole: A Biologically Active Scaffold

Mini-Reviews in Medicinal Chemistry, 2012
There has been considerable interest in the development of novel compounds with anticonvulsant, antidepressant, analgesic, anti-inflammatory, antiallergic, antipsychotic, antimicrobial, antimycobecterial, antitumour, antiviral and antitubercular activities. 1,3,4-oxadiazoles constitute an important class of compounds for new drug development. Therefore,
H, Khalilullah   +4 more
openaire   +2 more sources

Thermally Activated Delayed Fluorescence in 1,3,4-Oxadiazoles with π-Extended Donors.

Journal of Organic Chemistry, 2020
Here, we describe the synthesis of five 1,3,4-oxadiazole-based donor-acceptor materials, using dendritic carbazole-based donors 9'H-9,3':6'9″-tercarbazole (terCBz) and N3,N3,N6,N6-tetra-p-tolyl-9H-carbazole-3,6-diamine (TTAC).
Don M. Mayder   +2 more
semanticscholar   +1 more source

Aliphatic poly‐1,3,4‐oxadiazoles

Journal of Polymer Science Part A: General Papers, 1965
AbstractThree high molecular weight aliphatic polyoxadiazoles have been prepared by a new route from equimolar amounts of a diphenyl ester of dicarboxylic acid and an anhydrous hydrazine (or a dihydrazide). The resulting polymers have been characterized by microanalysis, intrinsic viscosity, x‐ray diffraction patterns, infrared absorption spectra, and ...
Terunobu Unishi, Masaki Hasegawa
openaire   +1 more source

Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis.

Future Medicinal Chemistry, 2019
AIM In recent times, heterocyclic chemotypes are being explored for the development of new antimycobacterials that target the drug-resistant tuberculosis.
Vitthal B. Makane   +9 more
semanticscholar   +1 more source

1,3,4‐Oxadiazoles

ChemInform, 2005
AbstractFor Abstract see ChemInform Abstract in Full Text.
openaire   +1 more source

Keto-1,3,4-oxadiazoles as cathepsin K inhibitors

Bioorganic & Medicinal Chemistry Letters, 2006
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
James T, Palmer   +6 more
openaire   +2 more sources

Recent progress of 1,3,4‐oxadiazoles as anticonvulsants: Future horizons

Archiv der Pharmazie, 2020
Epilepsy is the most common neurological disorder, which affects more than 50 million people worldwide. Despite the development and use of several antiepileptic drugs (AEDs), attempted seizure control fails in almost 30% of the individuals treated. Other
Shagufi Nazar, N. Siddiqui, O. Alam
semanticscholar   +1 more source

Novel syntheses of symmetrical 2,5-diaryl-1,3,4-oxadiazoles and 1,4-phenylenebis-1,3,4-oxadiazoles

Russian Chemical Bulletin, 1998
The reactions of trichloromethylarenes with excess hydrazine hydrate in ethanol gives symmetrical 2,5-diaryl-1,3,4-oxadiazoles in 68–96% yields. The reaction of 1,4-bis(trichloromethyl)benzene with acylhydrazines in an ethanol-pyridine mixture gives the corresponding substituted or unsubstituted 1,4-phenylenebis-1,3,4-oxadiazoles in 35–51% yields.
L. I. Belen'kii   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy